|
| |
|
DR. W HAQ |
|
| |
...
|
Chief Scientist
Medicinal and Process Chemistry Division
Central Drug Research Institute
Sector-10, Jankipuram Extension
Lucknow 226031, UP, India
|
| |
|
|
| |
| VISITS
ABROAD |
| |
|
• |
Visiting
Scientist- Nov. 1991-Feb. 1992- Dept. of Chemistry,
University of Arizona, USA |
• |
Visiting Scientist (DBT
Overseas Fellow)- Jan. 1994-Feb.19 95 Dept. of Chemistry,
University of Arizona, USA |
• |
Visiting scientist- August
22-26, 1995- Ferring Peptide Production AB, Malmo, Sweden |
• |
Visiting Investigator-
June 2003-Nov. 2004- Beckman Research Institute, Duarte,
CA, USA |
|
| |
| CURRENT
AREAS OF INTEREST |
|
•
|
Design and
synthesis of peptides and small organic molecules of therapeutic
interest |
|
|
| SELECTED
PUBLICATIONS |
| |
• |
Thiazolidin-4-one and thiazinan-4-one derivatives analogous to rosiglitazone as potential antihyperglycemic and antidyslipidemic agents. Raza S, Srivastava SP, Srivastava DS, Srivastava AK, Haq W, Katti SB. Eur J Med Chem. 2013, 63:611-20. |
• |
Augmentation of antileishmanial efficacy of miltefosine in combination with tuftsin against experimental visceral leishmaniasis. Shakya N, Sane SA, Haq W, Gupta S. Parasitol Res. 2012, 111(2):563-70. |
• |
Synthesis and pharmacological evaluation of novel arginine analogs as potential inhibitors of acetylcholine-induced relaxation in rat thoracic aortic rings. Jain M, Barthwal MK, Haq W, Katti SB, Dikshit M. Chem Biol Drug Des. 2012, 79(4):459-69 |
• |
Anti-stroke profile of thiazolidin-4-one derivatives in focal cerebral ischemia model in rat. Raghubir R, Verma R, Samuel SS, Raza S, Haq W, Katti SB. Chem Biol Drug Des. 2011, 78(3):445-53. |
• |
CpG oligodeoxynucleotide 2006 and miltefosine, a potential combination for treatment of experimental visceral leishmaniasis. Gupta S, Sane SA, Shakya N, Vishwakarma P, Haq W. Antimicrob Agents Chemother. 2011, 55(7):3461-4. |
| • |
Derivatives of human beta-casein fragments (54-59) exhibit highly potent immunosuppressant activity. Puri A, Bhattacharya M, Tripathi LM, Haq W. Int Immunopharmacol. 2009, 9(9):1092-6. |
| • |
Solomon VR,
Haq W, Srivastava K, Puri SK, Katti SB.
Synthesis and antimalarial activity of side chain modified
4-aminoquinoline derivatives. J Med Chem.
50, 394-8, 2007 |
| • |
Song GY, Gibson
G, Haq W, Huang EC, Srivastava T, Hollstein
M, Daftarian P, Wang Z, Diamond D, Ellenhorn JD. An MVA
vaccine overcomes tolerance to human p53 in mice and humans.
Cancer Immunol Immunother. 56, 1193-1205,
2007 |
| • |
Design, Synthesis
and Antimalarial activity of a new class of Iron chelators.
V. Raja Solomon, W. Haq, Sunil K. Puri,
Kumkum Srivastava, S.B. Katti. Medicinal Chemistry,
2, 133-8, 2006 |
| • |
Gupta CM,
Haq W. Tuftsin-bearing liposomes as antibiotic
carriers in treatment of macrophage infections. Methods
Enzymol. 391, 291-304, 2005 |
• |
Daftarian P, Sharan R,
Haq W, Ali S, Longmate J, Termini J,
Diamond DJ.Novel conjugates of epitope fusion peptides
with CpG-ODN display enhanced immunogenicity and HIV recognition.
Vaccine. 2005 May 16;23(26):3453-68. |
• |
Immunosuppressant activity
in human beta-casein fragment analogs. M. Bahattacharya,
A. Puri, R. Sahai, W. Haq, L.M. Tripathi and V.M.L. Srivastava.
Bioorganic Med. Chem. Lett. 8, 327-332,
1998. |
|
| |
| |
|
|
| |
|
| |
|